Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Unknown 2Completed 2Terminated 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 3Other solid neoplasm 2Genitourinary 2Breast 2Dermatologic 1

Conditions

Solid Tumor 1Advanced Solid Tumors 1

Interventions

Injections 17Cisplatin 15Carboplatin 15Oxaliplatin 11Gemcitabine 11pembrolizumab 8Capecitabine 8toripalimab 7Paclitaxel 7Etoposide 7Cyclophosphamide 7Pemetrexed 6Irinotecan 6Drug Therapy 6spartalizumab 5fludarabine 5camrelizumab 5Vincristine 5Radiotherapy 5Leucovorin 5tislelizumab 4apatinib 4anlotinib 4Interleukin-2 4Immune Checkpoint Inhibitors 4Granulocyte-Macrophage Colony-Stimulating Factor 4Fluorouracil 4Docetaxel 4Bevacizumab 4tremelimumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × tesetaxel × Other solid neoplasm × Clear all
NCT01315431 2012-07-24

A Study of Tesetaxel Plus Capecitabine in Patients With Solid Tumors

Genta Incorporated

Phase 1 Unknown
9 enrolled
Other solid neoplasm

Solid Tumor

NCT01337310 2012-03-13

Study of Tesetaxel in Japanese Patients With Solid Tumors

Genta Incorporated

Phase 1 Unknown
12 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡